Literature DB >> 2250718

Transfer of diabetes in mice prevented by blockade of adhesion-promoting receptor on macrophages.

P Hutchings1, H Rosen, L O'Reilly, E Simpson, S Gordon, A Cooke.   

Abstract

Insulin-dependent diabetes mellitus (IDDM) is a disease with an autoimmune aetiology. The non-obese diabetic mouse is a good spontaneous animal model of the human disease, with IDDM developing in 50-80% of female mice by the age of 6 months. The disease can be transferred by splenic T cells from diabetic donors and is prevented by T-cell depletion. The mechanism(s) by which the beta cell is specifically destroyed is not known, but T cells and macrophages have both been implicated, based on the presence of macrophages in the infiltrated islet and the ability of chronic silica treatment to prevent disease. The monoclonal antibody 5C6 is specific for the myelomonocytic adhesion-promoting type-3 complement receptor (CR3 or CD11b/CD18) and does not bind to T cells. Here we show that blockade of macrophage CR3 in vivo prevents intra-islet infiltration by both macrophages and T cells and inhibits development of IDDM. We conclude that both T cells and macrophages have an essential role in the onset of IDDM.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2250718     DOI: 10.1038/348639a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  66 in total

Review 1.  The differentiation of the immune system towards anti-islet autoimmunity. Clinical prospects.

Authors:  C Boitard
Journal:  Diabetologia       Date:  1992-12       Impact factor: 10.122

Review 2.  Immune cell crosstalk in type 1 diabetes.

Authors:  Agnès Lehuen; Julien Diana; Paola Zaccone; Anne Cooke
Journal:  Nat Rev Immunol       Date:  2010-07       Impact factor: 53.106

3.  Transfer of type II collagen-induced arthritis from DBA/1 to severe combined immunodeficiency mice can be prevented by blockade of Mac-1.

Authors:  P C Taylor; C Q Chu; C Plater-Zyberk; R N Maini
Journal:  Immunology       Date:  1996-06       Impact factor: 7.397

4.  CD18 deficiency protects against multiple low-dose streptozotocin-induced diabetes.

Authors:  Shayne C Barlow; Will Langston; Kametra M Matthews; John H Chidlow; Christopher G Kevil
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

Review 5.  Mechanisms and consequences of leukocyte-endothelial interaction.

Authors:  J M Harlan; N B Vedder; R K Winn; C L Rice
Journal:  West J Med       Date:  1991-10

Review 6.  Type 1 diabetes therapy beyond T cell targeting: monocytes, B cells, and innate lymphocytes.

Authors:  F Susan Wong; Li Wen
Journal:  Rev Diabet Stud       Date:  2012-12-28

7.  Hydrogen-bonded multilayers of tannic acid as mediators of T-cell immunity.

Authors:  Veronika Kozlovskaya; Bing Xue; Weiqi Lei; Lindsey E Padgett; Hubert M Tse; Eugenia Kharlampieva
Journal:  Adv Healthc Mater       Date:  2014-12-09       Impact factor: 9.933

Review 8.  Toll-like receptor-mediated immune responses in intestinal macrophages; implications for mucosal immunity and autoimmune diseases.

Authors:  Zejun Zhou; Miao Ding; Lei Huang; Gary Gilkeson; Ren Lang; Wei Jiang
Journal:  Clin Immunol       Date:  2016-09-09       Impact factor: 3.969

9.  Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice.

Authors:  David Bending; Hugo De la Peña; Marc Veldhoen; Jenny M Phillips; Catherine Uyttenhove; Brigitta Stockinger; Anne Cooke
Journal:  J Clin Invest       Date:  2009-02-02       Impact factor: 14.808

10.  Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.

Authors:  N Chosich; L C Harrison
Journal:  Diabetologia       Date:  1993-08       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.